Home > Healthcare > Biotechnology > Bioservices > Multi-omics Market

Multi-omics Market Size

Report ID: GMI7517
Published Date: Nov 2023
Report Format: PDF

Download Free Sample

Multi-omics Market Size

Multi-omics Market size was valued at USD 2.9 billion in 2022 and is estimated to grow at a CAGR of 15.2% between 2023 and 2032. One of the primary drivers is the continuous evolution and refinement of omics technologies. Advances in spatial genomics, transcriptomics, proteomics, metabolomics, and other omics disciplines contribute to the generation of vast and intricate datasets, providing researchers with a more comprehensive understanding of biological systems.

To get key market trends

Download Free Sample

Additionally, the increasing adoption of multi-omics approaches in various research domains, from basic biological studies to clinical applications, is fuelling market growth. Furthermore, the rising demand for personalized medicine and targeted therapies amplifies the market's expansion. All these aforementioned factors collectively contribute to the advancement of the market.

Multi-omics refers to an approach in biological research that involves the integration of data from multiple omics disciplines. Omics disciplines include genomics, transcriptomics, proteomics, metabolomics, and other omics fields that aim to characterize and quantify the components of biological systems.

Multi-omics Market Report Attributes
Report Attribute	Details
Base Year:	2022
Multi-omics Market Size in 2022:	USD 2.9 Billion
Forecast Period:	2023 to 2032
Forecast Period 2023 to 2032 CAGR:	15.2%
2032 Value Projection:	USD 12.2 Billion
Historical Data for:	2018 to 2022
No. of Pages:	210
Tables, Charts & Figures:	376
Segments covered:	Products & Services, Type, Platform, Application, End-use, & Region
Growth Drivers:	Advancements in omics technologies Increasing applications in personalized medicine Rising government initiatives and funding
Pitfalls & Challenges:	High cost of instruments and data storage Complex regulatory requirements and standardization issues

Learn more about the key segments shaping this market

Download Free Sample

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global multi-omics industry was valued at USD 2.9 billion in 2022 and is estimated to grow at a CAGR of 15.2% between 2023 and 2032, owing to the continuous evolution and refinement of omics technologies.

The oncology application is poised to reach USD 3.3 billion by 2032, as the integration of genomics, transcriptomics, proteomics, and metabolomics has allowed researchers and clinicians to unravel the complex landscape of cancer at a molecular level, paving the way for more targeted therapies.

North America market accounted for a revenue share of 46.8% in 2022 and will showcase high growth rate through 2032, attributed to substantial investments in R&D, a robust infrastructure for healthcare innovation, and a proactive regulatory environment fostering the adoption of multi-omics approaches.

Becton, Dickinson and Company, Thermo Fisher Scientific Inc., Illumina, Inc, Danaher, PerkinElmer Inc., Shimadzu Corporation, Bruker, QIAGEN, Agilent Technologies, Inc., and BGI among others.